Atlas Trials

EirGenix, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch EirGenix, Inc.

RecordFirmDate
Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer. (NCT06884254)EirGenix, Inc.2025-05-01
A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers (NCT05471648)EirGenix, Inc.2022-05-16
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer (NCT03433313)EirGenix, Inc.2018-10-16

Track EirGenix, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.